Cargando…

Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease

Background. Paraoxonase-1 (PON1) is the crucial antioxidant marker of high-density lipoproteins. The present study is aimed at assessing the effect of simvastatin treatment on PON1 activity and its relationship to Q192R and M55L polymorphisms in subjects with stable coronary artery disease (CAD). Me...

Descripción completa

Detalles Bibliográficos
Autor principal:	Januszek, Rafał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860225/ https://www.ncbi.nlm.nih.gov/pubmed/27213056 http://dx.doi.org/10.1155/2016/6312478

Ejemplares similares

Low Paraoxonase 1 Arylesterase Activity and High von Willebrand Factor Levels are Associated with Severe Coronary Atherosclerosis in Patients with Non-Diabetic Stable Coronary Artery Disease
por: Ding, Jieying, et al.
Publicado: (2014)

Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia
por: Ballard, Kevin D., et al.
Publicado: (2015)

Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-Syndrome-Related Risk of Coronary Artery Disease
por: Martinelli, Nicola, et al.
Publicado: (2012)

Long-term outcomes of percutaneous coronary interventions within coronary artery bypass grafts
por: Januszek, Rafał, et al.
Publicado: (2019)

Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease
por: Shek, Aleksandr B., et al.
Publicado: (2017)

Concomitant multi-vessel disease is associated with a lower procedural death rate in patients treated with percutaneous coronary interventions within the left main coronary artery (from the ORPKI registry)
por: Januszek, Rafał, et al.
Publicado: (2019)

High Prevalence of Low Serum Paraoxonase-1 in Subjects with Coronary Artery Disease
por: Jayakumari, Narayani, et al.
Publicado: (2009)

Reduced Paraoxonase 1 Activity as a Marker for Severe Coronary Artery Disease
por: Zhou, Chiyan, et al.
Publicado: (2013)

Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial
por: Sbrana, Silverio, et al.
Publicado: (2020)

Effects of Community-Based Cardiac Rehabilitation on Body Composition and Physical Function in Individuals with Stable Coronary Artery Disease: 1.6-Year Followup
por: Mandic, Sandra, et al.
Publicado: (2013)

The Role of Simvastatin in the Therapeutic Approach of Rheumatoid Arthritis
por: Cojocaru, Lucia, et al.
Publicado: (2013)

Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2019)

Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
por: Mackness, Bharti, et al.
Publicado: (2013)

Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease
por: Priyanka, Kumari, et al.
Publicado: (2019)

Low serum paraoxonase1 activity levels predict coronary artery disease severity
por: Sun, Ting, et al.
Publicado: (2016)

Levels of Oxidized LDL, Estrogens, and Progesterone in Placenta Tissues and Serum Paraoxonase Activity in Preeclampsia
por: Açıkgöz, Şerefden, et al.
Publicado: (2013)

Phenotype distribution of the paraoxonase gene in patients with cardiac disease
por: Ellidag, Hamit Yasar, et al.
Publicado: (2016)

Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery
por: Wysocka, Anna, et al.
Publicado: (2014)

Exploring the Role of Paraoxonases in the Pathogenesis of Coronary Artery Disease: A Systematic Review
por: Abelló, David, et al.
Publicado: (2014)

Paraoxonase gene polymorphisms: Understanding the biochemical and genetic basis of coronary artery disease
por: Nasreen, Fathima J., et al.
Publicado: (2022)

Predictive values of coronary artery calcium and arterial stiffness for long‐term cardiovascular events in patients with stable coronary artery disease
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Further Increase in the Expression of Activation Markers on Monocyte-Derived Dendritic Cells in Coronary Artery Disease Patients with Ectasia Compared to Patients with Coronary Artery Disease Alone
por: Yildirim, Nesligul, et al.
Publicado: (2010)

Coronary artery lesion distribution in patients with chronic kidney disease undergoing percutaneous coronary intervention
por: Ikeda, Naofumi, et al.
Publicado: (2022)

PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting
por: Wojtkowska, Izabela, et al.
Publicado: (2014)

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
por: Rotella, Carlo M, et al.
Publicado: (2010)

Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery
por: Wysocka, Anna, et al.
Publicado: (2019)

Serum paraoxonase 1 activity in patients with iron deficiency anemia
por: Okuturlar, Yildiz, et al.
Publicado: (2016)

Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
por: Chen, Xue, et al.
Publicado: (2020)

Efficacy and Mechanism of Preoperative Simvastatin Therapy on Myocardial Protection after Extracorporeal Circulation
por: Hua, Ping, et al.
Publicado: (2017)

Immunohistochemical Analysis of Paraoxonases and Chemokines in Arteries of Patients with Peripheral Artery Disease
por: Hernández-Aguilera, Anna, et al.
Publicado: (2015)

A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
por: Njerve, Ida Unhammer, et al.
Publicado: (2017)

Brachial Artery Endothelial Responses during Early Recovery from an Exercise Bout in Patients with Coronary Artery Disease
por: Currie, Katharine D., et al.
Publicado: (2014)

Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary artery bypass grafts
por: Januszek, Rafał A., et al.
Publicado: (2020)

Impact of the De Ritis Ratio on the Prognosis of Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Wang, Kai, et al.
Publicado: (2022)

Analyzing Coronary Artery Disease in Patients with Low CAC Scores by 64-Slice MDCT
por: Lu, Nan-Han, et al.
Publicado: (2012)

The Effect of Park and Urban Environments on Coronary Artery Disease Patients: A Randomized Trial
por: Grazuleviciene, Regina, et al.
Publicado: (2015)

Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial
por: D’Amario, D., et al.
Publicado: (2020)

Highly sensitive troponin I assay in the diagnosis of coronary artery disease in patients with suspected stable angina
por: Ramasamy, Indra
Publicado: (2021)

Effect of Simvastatin and Atorvastatin on Serum Vitamin D and Bone Mineral Density in Hypercholesterolemic Patients: A Cross-Sectional Study
por: Thabit, K. Abrar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oeofndrej1nsav07321kk1negj